 |
 |

Autosomal Dominant Hemorrhagic Macular Dystrophy Not Associated With the TIMP3 Gene
Radha Ayyagari, PhD;
Irina B. Griesinger, PhD;
Eve Bingham;
Kurt K. Lark, MD;
Sayoko E. Moroi, MD, PhD;
Paul A. Sieving, MD, PhD
Arch Ophthalmol. 2000;118:85-92.
Objective To describe the ophthalmic and genetic findings of a large kindred (UM:H389) with autosomal dominant hemorrhagic macular dystrophy.
Methods The disease state of family members was documented by dilated fundus examination, electroretinography, color vision tests, fluorescein angiography, measurement of visual fields, biomicroscopy, gonioscopy, and intraocular pressure measurement. Linkage and haplotype analyses were carried out with markers flanking the Sorsby fundus dystrophy TIMP3 (tissue inhibitor of metalloproteinase 3) gene locus, and mutation analysis was carried out by screening exon 5 of the TIMP3 gene.
Results This 4-generation pedigree with autosomal dominant hemorrhagic macular degeneration has visual symptoms beginning in the sixth decade of life. Several family members developed choroidal neovascular membrane formation in the macula of both eyes. The phenotype overlaps that of Sorsby fundus dystrophy. Some of the affected members have unusual zonularlike radial striations on the anterior lens capsule surface, and glaucoma or ocular hypertension has developed in 2 of them. Involvement of the TIMP3 gene was excluded by linkage, haplotype, and mutation analyses.
Conclusions The phenotype of this family with autosomal dominant macular dystrophy overlaps that of Sorsby fundus dystrophy. Exclusion of the TIMP3 gene in this family indicates genetic heterogeneity for hemorrhagic macular dystrophy. Anterior segment anomalies may occur with this condition, but cosegregation has not yet been established.
Clinical Relevance This study broadens the spectrum of hemorrhagic macular dystrophy by identifying a family in which the TIMP3 gene is not involved. Once the gene is cloned, we are eager to learn whether this gene may be involved in age-related macular degeneration.
From the W. K. Kellogg Eye Center, University of Michigan, Ann Arbor.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
Borooah et al.
Postgrad. Med. J. 2009;85:495-500.
ABSTRACT
| FULL TEXT
Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
Borooah et al.
Br J Ophthalmol 2009;93:284-289.
ABSTRACT
| FULL TEXT
CTRP5 Is a Membrane-Associated and Secretory Protein in the RPE and Ciliary Body and the S163R Mutation of CTRP5 Impairs Its Secretion
Mandal et al.
IOVS 2006;47:5505-5513.
ABSTRACT
| FULL TEXT
Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5
Shu et al.
Hum Mol Genet 2006;15:1680-1689.
ABSTRACT
| FULL TEXT
Late-Onset Macular Degeneration and Long Anterior Lens Zonules Result from a CTRP5 Gene Mutation
Ayyagari et al.
IOVS 2005;46:3363-3371.
ABSTRACT
| FULL TEXT
Late-Onset Autosomal Dominant Macular Dystrophy with Choroidal Neovascularization and Nonexudative Maculopathy Associated with Mutation in the RDS Gene
Khani et al.
IOVS 2003;44:3570-3577.
ABSTRACT
| FULL TEXT
Frequent Methylation-Associated Silencing of the Tissue Inhibitor of Metalloproteinase-3 Gene in Pancreatic Endocrine Tumors
Wild et al.
J. Clin. Endocrinol. Metab. 2003;88:1367-1373.
ABSTRACT
| FULL TEXT
|